Drugs / MEBO
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01138436 | Nov 2010 → Oct 2011 | ulcer disease | Skingenix, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MEBO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01138436 ↗ |
| Route | Topical | “Topical application once a day” NCT01138436 ↗ |